AAAAAA

   
Results: 1-25 |
Results: 25
In vitro anti-HIV-1 synergy between non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz
Authors: Kollmann, C Tremblay, C Giguel, F Chou, TC Hirsch, MS
Citation: C. Kollmann et al., In vitro anti-HIV-1 synergy between non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz, ANTIVIR TH, 6(2), 2001, pp. 143-144
Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression
Authors: Havlir, DV Gilbert, PB Bennett, K Collier, AC Hirsch, MS Tebas, P Adams, EM Wheat, LJ Goodwin, D Schnittman, S Holohan, MK Richman, DD
Citation: Dv. Havlir et al., Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression, AIDS, 15(11), 2001, pp. 1379-1388
HIV fusion and its inhibition
Authors: LaBranche, CC Galasso, G Moore, JP Bolognesi, DP Hirsch, MS Hammer, SM
Citation: Cc. Labranche et al., HIV fusion and its inhibition, ANTIVIR RES, 50(2), 2001, pp. 95-115
Prevalence and predictive value of intermittent viremia with combination HIV therapy
Authors: Havlir, DV Bassett, R Levitan, D Gilbert, P Tebas, P Collier, AC Hirsch, MS Ignacio, C Condra, J Gunthard, HF Richman, DD Wong, JK
Citation: Dv. Havlir et al., Prevalence and predictive value of intermittent viremia with combination HIV therapy, J AM MED A, 286(2), 2001, pp. 171-179
Alterations in T cell phenotype and human immunodeficiency virus type 1 - Specific cytotoxicity after potent antiretroviral therapy
Authors: Seth, A Markee, J Hoering, A Sevin, A Sabath, DE Schmitz, RE Kuroda, MJ Lifton, MA Hirsch, MS Collier, AC Letvin, NL McElrath, J
Citation: A. Seth et al., Alterations in T cell phenotype and human immunodeficiency virus type 1 - Specific cytotoxicity after potent antiretroviral therapy, J INFEC DIS, 183(5), 2001, pp. 722-729
Multiple asymptomatic plexiform schwannomas of the sigmoid colon: a case report and review
Authors: Jacobson, BC Hirsch, MS Lee, JH Van Dam, J Shoji, B Farraye, FA
Citation: Bc. Jacobson et al., Multiple asymptomatic plexiform schwannomas of the sigmoid colon: a case report and review, GASTROIN EN, 53(7), 2001, pp. 801-804
Combination antiretroviral therapy
Authors: Tremblay, C Kaplan, JC Hirsch, MS
Citation: C. Tremblay et al., Combination antiretroviral therapy, ANTIRETROVIRAL THERAPY, 2001, pp. 313-337
Strong in vitro synergy between the fusion inhibitor T-20 and the CXCR4 blocker AMD-3100
Authors: Tremblay, CL Kollmann, C Giguel, F Chou, TC Hirsch, MS
Citation: Cl. Tremblay et al., Strong in vitro synergy between the fusion inhibitor T-20 and the CXCR4 blocker AMD-3100, J ACQ IMM D, 25(2), 2000, pp. 99-102
In vitro inhibition of HIV-1 by Met-SDF-1 beta alone or in combination with antiretroviral drugs
Authors: Rusconi, S Merill, DP Catamancio, SL Citterio, P Bulgheroni, E Croce, F Chou, TC Yang, OO Herrmann, SH Galli, M Hirsch, MS
Citation: S. Rusconi et al., In vitro inhibition of HIV-1 by Met-SDF-1 beta alone or in combination with antiretroviral drugs, ANTIVIR TH, 5(3), 2000, pp. 199-204
Viability and functional activity of cryopreserved mononuclear cells
Authors: Weinberg, A Zhang, L Brown, D Erice, A Polsky, B Hirsch, MS Owens, S Lamb, K
Citation: A. Weinberg et al., Viability and functional activity of cryopreserved mononuclear cells, CL DIAG LAB, 7(4), 2000, pp. 714-716
Dynamics of HIV-1 viral load rebound among patients with previous suppression of viral replication
Authors: Ioannidis, JPA Havlir, DV Tebas, P Hirsch, MS Collier, AC Richman, DD
Citation: Jpa. Ioannidis et al., Dynamics of HIV-1 viral load rebound among patients with previous suppression of viral replication, AIDS, 14(11), 2000, pp. 1481-1488
The role of genotypic resistance testing in selecting therapy for HIV - Reply
Authors: Hirsch, MS Richman, DD
Citation: Ms. Hirsch et Dd. Richman, The role of genotypic resistance testing in selecting therapy for HIV - Reply, J AM MED A, 284(13), 2000, pp. 1650-1650
Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel
Authors: Carpenter, CCJ Cooper, DA Fischl, MA Gatell, JM Gazzard, BG Hammer, SM Hirsch, MS Jacobsen, DM Katzenstein, DA Montaner, JSG Richman, DD Saag, MS Schechter, M Schooley, RT Vella, S Yeni, PG Volberding, PA
Citation: Ccj. Carpenter et al., Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel, J AM MED A, 283(3), 2000, pp. 381-390
Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens
Authors: Havlir, DV Hellmann, NS Petropoulos, CJ Whitcomb, JM Collier, AC Hirsch, MS Tebas, P Sommadossi, JP Richman, DD
Citation: Dv. Havlir et al., Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens, J AM MED A, 283(2), 2000, pp. 229-234
Antiretroviral drug resistance testing in adult HIV-1 infection - Recommendations of an International AIDS Society-USA panel
Authors: Hirsch, MS Brun-Vezinet, F D'Aquila, RT Hammer, SM Johnson, VA Kuritzkes, DR Loveday, C Mellors, JW Clotet, B Conway, B Demeter, LM Vella, S Jacobsen, DM Richman, DD
Citation: Ms. Hirsch et al., Antiretroviral drug resistance testing in adult HIV-1 infection - Recommendations of an International AIDS Society-USA panel, J AM MED A, 283(18), 2000, pp. 2417-2426
Marked differences in quantity of infectious human immunodeficiency virus type 1 detected in persons with controlled plasma viremia by a simple enhanced culture method
Authors: Tremblay, CL Giguel, F Merrill, DP Wong, JT Rosenberg, E Kalams, S Walker, BD D'Aquila, RT Hirsch, MS
Citation: Cl. Tremblay et al., Marked differences in quantity of infectious human immunodeficiency virus type 1 detected in persons with controlled plasma viremia by a simple enhanced culture method, J CLIN MICR, 38(11), 2000, pp. 4246-4248
Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection: In vitro studies of mixed virus infections
Authors: Rusconi, S Catamancio, SL Citterio, P Bulgheroni, E Croce, F Herrmann, SH Offord, RE Galli, M Hirsch, MS
Citation: S. Rusconi et al., Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection: In vitro studies of mixed virus infections, J VIROLOGY, 74(19), 2000, pp. 9328-9332
Two double-blinded, randomized, comparative trials of 4 human immunodeficiency virus type 1 (HIV-1) envelope vaccines in HIV-1-infected individuals across a spectrum of disease severity: AIDS clinical trials groups 209 and 214
Authors: Schooley, RT Spino, C Kuritzkes, D Walker, BD Valentine, FT Hirsch, MS Cooney, E Friedland, G Kundu, S Merigan, TC McElrath, MJ Collier, A Plaeger, S Mitsuyasu, R Kahn, J Haslett, P Uherova, P deGruttola, V Chiu, S Zhang, B Jones, G Bell, D Ketter, N Twadell, T Chernoff, D Rosandich, M
Citation: Rt. Schooley et al., Two double-blinded, randomized, comparative trials of 4 human immunodeficiency virus type 1 (HIV-1) envelope vaccines in HIV-1-infected individuals across a spectrum of disease severity: AIDS clinical trials groups 209 and 214, J INFEC DIS, 182(5), 2000, pp. 1357-1364
Interactions among combinations of two and three protease inhibitors against drug-susceptible and drug-resistant HIV-1 isolates
Authors: Tremblay, C Merrill, DP Chou, TC Hirsch, MS
Citation: C. Tremblay et al., Interactions among combinations of two and three protease inhibitors against drug-susceptible and drug-resistant HIV-1 isolates, J ACQ IMM D, 22(5), 1999, pp. 430-436
Induction and maintenance treatment regimens for HIV-1 infection in vitro
Authors: Oh, MD Merrill, DP Hirsch, MS
Citation: Md. Oh et al., Induction and maintenance treatment regimens for HIV-1 infection in vitro, ANTIVIR TH, 4(1), 1999, pp. 29-34
Effective inhibition of HIV-1 isolated from patients with acute primary HIV-1 infection by aminooxypentane-RANTES
Authors: Rusconi, S Merrill, DP La Seta-Catamancio, S Citterio, P Offord, RE Hirsch, MS
Citation: S. Rusconi et al., Effective inhibition of HIV-1 isolated from patients with acute primary HIV-1 infection by aminooxypentane-RANTES, AIDS, 13(9), 1999, pp. 1144-1145
IAS position paper on prevention of HIV1 mother-to-child transmission
Authors: Hirsch, MS Wilfert, C Ammann, A Coovadia, HM Cu-Uvin, S Dabis, F Ekpini, RAE Kallings, LO Mofenson, L Tess, B Bryson, Y Cao, Y Chotpitayasunondh, T Nduati, R Solomon, S
Citation: Ms. Hirsch et al., IAS position paper on prevention of HIV1 mother-to-child transmission, AIDS, 13(11), 1999, pp. A5-A9
Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients
Authors: Zhou, XJ Sheiner, LB D'Aquila, RT Hughes, MD Hirsch, MS Fischl, MA Johnson, VA Myers, M Sommadossi, JP
Citation: Xj. Zhou et al., Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients, ANTIM AG CH, 43(1), 1999, pp. 121-128
Coalescent estimates of HIV-1 generation time in vivo
Authors: Rodrigo, AG Shpaer, EG Delwart, EL Iversen, AKN Gallo, MV Brojatsch, J Hirsch, MS Walker, BD Mullins, JI
Citation: Ag. Rodrigo et al., Coalescent estimates of HIV-1 generation time in vivo, P NAS US, 96(5), 1999, pp. 2187-2191
Improved CD4 lymphocyte outgrowth in response to effective antiretroviral therapy
Authors: Merrill, DP Martinez-Picado, J Tremblay, C Sax, PE Boswell, SL Wong, JT D'Aquila, RT Walker, BD Hirsch, MS
Citation: Dp. Merrill et al., Improved CD4 lymphocyte outgrowth in response to effective antiretroviral therapy, J INFEC DIS, 179(2), 1999, pp. 345-351
Risultati: 1-25 |